Vitamin B12: a Biological Marker of Systemic Disease or Infection Flare-up in Patients Treated with Tocilizumab?

Clinical trial NCT06654154 · RECRUITING

Trial details

NCT number: NCT06654154
Sponsor: University Hospital, Clermont-Ferrand
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Level of Serum Vitamin B12 Level (in Pmol/L) If Relapse of (AI/ID) Under Tocilizumab Level of Serum Vitamin B12 Level (in Pmol/L) If Infection Under Tocilizumab

Start date: 2024-04-03
Primary completion: 2026-03-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.